Abstract
The advent of omics technologies as genomics and proteomics has brought the hope of discovering novel biomarkers that can be used to diagnose, predict, and monitor progress of disease. The importance of computational biomarker discovery for diagnostic classification and prognostic assessment in the context of microarray and proteomic data has been increasingly recognized. We present an overview of computational methods and their applications to biomarker discovery with particular focus on genomics and proteomics data. One case study is exemplarily presented, and relevant computational biomarker discovery terminology and techniques are explained.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Soreide K (2009) Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol 62(1):1–5
Jaffe CC (2009) Pathology and imaging in biomarker development. Arch Pathol Lab Med 133(4):547–549
Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM, Rubin MA (2003) Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J Natl Cancer Inst 95(9):661–668
Allison DB, Cui X, Page GP, Sabripour M (2006) Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 7(1):55–65
Reimers M (2010) Making informed choices about microarray data analysis. PLoS Comput Biol 6(5):e1000786
Slonim DK, Yanai I (2009) Getting started in gene expression microarray analysis. PLoS Comput Biol 5(10):e1000543
Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Van De Rijn M, Jeffrey SS (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98(19):10869–10874
Giltnane JM, Rimm DL (2004) Technology insight: identification of biomarkers with tissue microarray technology. Nat Clin Pract Oncol 1(2):104–111
Segal E, Friedman N, Kaminski N, Regev A, Koller D (2005) From signatures to models: understanding cancer using microarrays. Nat Genet 37:S38–S45
Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, Cragun J, Cottrill H, Kelley MJ, Petersen R (2006) Genomic signatures to guide the use of chemotherapeutics. Nat Med 12(11):1294–1300
Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1–13
Khatri P, Draghici S (2005) Ontological analysis of gene expression data: current tools, limitations, and open problems. Bioinformatics 21(18):3587–3595
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 102(43):15545–15550
Glez-Pena D, Gomez-Lopez G, Pisano DG, Fdez-Riverola F (2009) WhichGenes: a web-based tool for gathering, building, storing and exporting gene sets with application in gene set enrichment analysis. Nucleic Acids Res 37(Web Server Issue):W329–W334
Medina I, Montaner D, Bonifaci N, Pujana MA, Carbonell J, Tarraga J, Al-Shahrour F, Dopazo J (2009) Gene set-based analysis of polymorphisms: finding pathways or biological processes associated to traits in genome-wide association studies. Nucleic Acids Res 37(Web Server Issue):W340–W344
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4(9):R60
Pujana MA, Han JDJ, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B (2007) Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 39(11):1338–1349
Chuang HY, Lee E, Liu YT, Lee D, Ideker T (2007) Network-based classification of breast cancer metastasis. Mol Syst Biol 3(1):140–149
Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, Bainbridge M, Dinh H, Jing C, Wheeler DA et al (2010) Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 362(13):1181–1191
Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, Rowen L, Pant KP, Goodman N, Bamshad M et al (2010) Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 328(5978):636–639
Chan D (2006) Clinical proteomics. Clin Proteomics 2(1):1–4
Hanash S (2004) Moving forward with clinical proteomics. Clin Proteomics 1(1):3–5
Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominiczak A, Ehrich JHH, Fliser D, Girolami M, Hermjakob H et al (2007) Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl 1(2):148–156
Klampfl CW (2004) Review coupling of capillary electrochromatography to mass spectrometry. J Chromatogr A 1044(1–2):131–144
Frohlich T, Arnold GJ (2006) Proteome research based on modern liquid chromatography–tandem mass spectrometry: separation, identification and quantification. J Neural Transm 113(8):973–994
Mbeunkui F, Metge BJ, Shevde LA, Pannell LK (2007) Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. J Proteome Res 6(8):2993–3002
Needham CJ, Bradford JR, Bulpitt AJ, Westhead DR (2006) Inference in Bayesian networks. Nat Biotechnol 24(1):51–53
Lai KC, Chiang HC, Chen WC, Tsai FJ, Jeng LB (2008) Artificial neural network-based study can predict gastric cancer staging. Hepatogastroenterology 55(86–87):1859–1863
Amiri Z, Mohammad K, Mahmoudi M, Zeraati H, Fotouhi A (2008) Assessment of gastric cancer survival: using an artificial hierarchical neural network. Pak J Biol Sci 11(8):1076–1084
Chi CL, Street WN, Wolberg WH (2007) Application of artificial neural network-based survival analysis on two breast cancer datasets. AMIA Annu Symp Proc 2007:130–134
Anagnostopoulos I, Maglogiannis I (2006) Neural network-based diagnostic and prognostic estimations in breast cancer microscopic instances. Med Biol Eng Comput 44(9):773–784
Wang HQ, Wong HS, Zhu H, Yip TT (2009) A neural network-based biomarker association information extraction approach for cancer classification. J Biomed Inform 42(4):654–666
Meyer D, Leisch F, Hornik K (2003) The support vector machine under test. Neurocomputing 55(1–2):169–186
Vapnik VN (1998) Statistical learning theory. Springer, New York
Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M et al (2004) UniProt: the Universal Protein knowledgebase. Nucleic Acids Res 32(Database Issue):D115–D119
Chen J, Aronow BJ, Jegga AG (2009) Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinforma 10:73
Kohler S, Bauer S, Horn D, Robinson PN (2008) Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 82(4):949–958
Oti M, Snel B, Huynen MA, Brunner HG (2006) Predicting disease genes using protein-protein interactions. J Med Genet 43(8):691–698
Chen JY, Shen C, Sivachenko AY (2006) Mining Alzheimer disease relevant proteins from integrated protein interactome data. Pac Symp Biocomput 2006:367–378
Xu J, Li Y (2006) Discovering disease-genes by topological features in human protein-protein interaction network. Bioinformatics 22(22):2800–2805
Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA (2005) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33(Database Issue):D514–D517
Page L, Brin S, Motwani R, Winograd T (1999) The PageRank citation ranking: bringing order to the web. Technical report, Stanford InfoLab, Nov 1999
Kleinberg JM (1999) Authoritative sources in a hyperlinked environment. J ACM 46(5):604–632
Wu X, Pandey R, Chen JY (2009) Network topological reordering revealing systemic patterns in yeast protein interaction networks. Conf Proc IEEE Eng Med Biol Soc 2009:6954–6957
Huang H, Li J, Chen JY (2009) Disease gene-fishing in molecular interaction networks: a case study in colorectal cancer. Conf Proc IEEE Eng Med Biol Soc 2009:6416–6419
Goymer P (2007) Cancer genetics: networks uncover new cancer susceptibility suspect. Nat Rev Genet 8:823
Ergün A, Lawrence CA, Kohanski MA, Brennan TA, Collins JJ (2007) A network biology approach to prostate cancer. Mol Syst Biol 3:82
Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32(Database Issue):D277–D280
Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, de Bono B, Garapati P, Hemish J, Hermjakob H, Jassal B et al (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 37(Database Issue):D619–D622
Bader GD, Cary MP, Sander C (2006) Pathguide: a pathway resource list. Nucleic Acids Res 34(Database Issue):D504–D506
Karp PD, Ouzounis CA, Moore-Kochlacs C, Goldovsky L, Kaipa P, Ahren D, Tsoka S, Darzentas N, Kunin V, Lopez-Bigas N (2005) Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res 33(19):6083–6089
Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH (2009) PID: the pathway interaction database. Nucleic Acids Res 37(Database Issue):D674–D679
Rao PN, Levine E, Myers MO, Prakash V, Watson J, Stolier A, Kopicko JJ, Kissinger P, Raj SG, Raj MH (1999) Elevation of serum riboflavin carrier protein in breast cancer. Cancer Epidemiol Biomarkers Prev 8(11):985–990
Dua RS, Isacke CM, Gui GPH (2006) The intraductal approach to breast cancer biomarker discovery. J Clin Oncol 24(7):1209–1216
Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J et al (2008) Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. J Proteome Res 7(4):1518–1528
Alexander H, Stegner AL, Wagner-Mann C, Du Bois GC, Alexander S, Sauter ER (2004) Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res 10(22):7500–7510
Adam PJ, Boyd R, Tyson KL, Fletcher GC, Stamps A, Hudson L, Poyser HR, Redpath N, Griffiths M, Steers G et al (2003) Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem 278(8):6482–6489
Bullinger D, Neubauer H, Fehm T, Laufer S, Gleiter CH, Kammerer B (2007) Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling. BMC Biochem 8:25
Kulasingam V, Diamandis EP (2007) Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol Cell Proteomics 6(11):1997–2011
Xiang R, Shi Y, Dillon DA, Negin B, Horvath C, Wilkins JA (2004) 2D LC/MS analysis of membrane proteins from breast cancer cell lines MCF7 and BT474. J Proteome Res 3(6):1278–1283
Burdall S, Hanby A, Lansdown M, Speirs V (2003) Breast cancer cell lines: friend or foe? Breast Cancer Res 5(2):89–95
Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE (2005) Comprehensive label-free method for the relative quantification of proteins from biological samples. J Proteome Res 4(4):1442–1450
Berishaj M, Gao SP, Ahmed S, Leslie K, Al-Ahmadie H, Gerald WL, Bornmann W, Bromberg JF (2007) Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res 9(3):R32
Hu H, Lee HJ, Jiang C, Zhang J, Wang L, Zhao Y, Xiang Q, Lee EO, Kim SH, Lu J (2008) Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol Cancer Ther 7(9):2681–2691
Song H, Jin X, Lin J (2004) Stat3 upregulates MEK5 expression in human breast cancer cells. Oncogene 23(50):8301–8309
Nielsen NR, Gronbaek M (2006) Stress and breast cancer: a systematic update on the current knowledge. Nat Clin Pract Oncol 3(11):612–620
Zhang F, Chen JY (2010) Discovery of pathway biomarkers from coupled proteomics and systems biology methods. BMC Genomics 11(Suppl 2):S12
Ideker T (2004) Systems biology 101: what you need to know. Nat Biotechnol 22(4):473–475
Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33(3 s):238–244
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087–1095
Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, Friedman E, Narod S, Olshen AB, Gregersen P (2008) Genome-wide association study provides evidence for a breast cancer risk locus at 6q22. 33. Proc Natl Acad Sci 105(11):4340
Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell’s functional organization. Nat Rev Genet 5(2):101–113
Goldberger AL, Amaral LAN, Hausdorff JM, Ivanov PC, Peng CK, Stanley HE (2002) Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci 99(90001):2466–2472
Amaral LAN, Diaz-Guilera A, Moreira AA, Goldberger AL, Lipsitz LA, Kopell NJ (2004) Emergence of complex dynamics in a simple model of signaling networks. Proc Natl Acad Sci U S A 101(44):15551–15555
Costa M, Goldberger AL, Peng CK (2005) Broken asymmetry of the human heartbeat: loss of time irreversibility in aging and disease. Phys Rev Lett 95(19):198102–198105
Goldberger AL, Moody GB, Peng CK (2006) Techniques, applications and future directions, Heart Rate Viability 2006 Workshop, 20–23 April 2006
Tatsumi J, Yamauchi A, Kono Y (1989) Fractal analysis of plant root systems. Ann Bot 64(5):499
Palmer MW (1988) Fractal geometry: a tool for describing spatial patterns of plant communities. Plant Ecol 75(1):91–102
Peitgen HO, Jugens H, Saupe D (2004) Chaos and fractals: new frontiers of science. Springer, New York
Auffray C (2007) Protein subnetwork markers improve prediction of cancer outcome. Mol Syst Biol 3:141–142
Nolan GP (2007) What’s wrong with drug screening today. Nat Chem Biol 3:187–191
McCarthy N (2007) Tumour profiling: networking, protein style. Nat Rev Cancer 7:892–893
Morrison JL, Breitling R, Higham DJ, Gilbert DR (2005) GeneRank: using search engine technology for the analysis of microarray experiments. BMC Bioinforma 6(1):233
Bar-Joseph Z, Gifford DK, Jaakkola TS (2001) Fast optimal leaf ordering for hierarchical clustering. Bioinformatics 17(Suppl 1):S22–S29
Kim SK, Lund J, Kiraly M, Duke K, Jiang M, Stuart JM, Eizinger A, Wylie BN, Davidson GS (2001) A gene expression map for Caenorhabditis elegans. Science 293(5537):2087–2092
You Q, Fang S, Chen JY (2008) GeneTerrain: visual exploration of differential gene expression profiles organized in native biomolecular interaction networks. Inf Vis 9(1):1–12. doi:10.1057
Acknowledgements
This work was supported in part by a grant from the National Cancer Institute (U24CA126480-01), part of NCI’s Clinical Proteomic Technologies Initiative (http://proteomics.cancer.gov), awarded to Dr. Fred Regnier (PI) and Dr. Jake Chen (co-PI).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zhang, F., Wu, X., Chen, J.Y. (2014). Computational Biomarker Discovery. In: Chen, M., Hofestädt, R. (eds) Approaches in Integrative Bioinformatics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41281-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-41281-3_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41280-6
Online ISBN: 978-3-642-41281-3
eBook Packages: Computer ScienceComputer Science (R0)